Dendritic cell–tumor cell hybrids and immunotherapy: what's next?

Author： Cathelin Dominique   Nicolas Alexandra   Bouchot André   Fraszczak Jennifer   Labbé Jérôme   Bonnotte Bernard  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.13, Iss.7, 2011-08, pp. : 774-785

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy in the B-cell lymphomas

By Gribben JG  

Cytotherapy, Vol. 4, Iss. 5, 2002-09 ,pp. : 439-440

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Follicular Dendritic Cell Sarcoma

By  

Acta Cytologica, Vol. 52, Iss. 2, 2011-02 ,pp. : 235-239

Karger

Access to resources Recommend Favorite

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery

By Li Hui   Wang Changli   Yu Jinpu   Cao Shui   Wei Feng   Zhang Weihong   Han Ying   Ren Xiu-bao  

Cytotherapy, Vol. 11, Iss. 8, 2009-11 ,pp. : 1076-1083

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Intraabdominal Follicular Dendritic Cell Sarcoma

By  

Acta Cytologica, Vol. 45, Iss. 6, 2011-04 ,pp. : 999-1004

Karger

Access to resources Recommend Favorite

Sertoli Cell Tumor of the Testis

By  

Acta Cytologica, Vol. 42, Iss. 6, 2011-08 ,pp. : 1458-1460

Karger

Access to resources Recommend Favorite